Evidence map›Paper›PMID 37488417›Full record

ArticleNature genetics2023

Dynamic network-guided CRISPRi screen identifies CTCF-loop-constrained nonlinear enhancer gene regulatory activity during cell state transitions.

Renhe Luo, Jielin Yan, Jin Woo Oh, Wang Xi, Dustin Shigaki, Wilfred Wong, Hyein S Cho, Dylan Murphy, Ronald Cutler, Bess P Rosen and 10 more

Open access · greenAbstract read
In one paragraph

Article in Nature genetics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Aberrant Enhancer Regulation, Phase Separation, and Autoimmune Diseases.Clinical reviews in allergy & immunology · 2025
    Review
  16. Article
  17. High expression ofBiochemistry and biophysics reports · 2025
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors at 5 institutions in 1 country.

Renhe LuoDevelopmental Biology Program, Sloan Kettering Institute, New York City, NY, USA.
Jielin YanDevelopmental Biology Program, Sloan Kettering Institute, New York City, NY, USA.
Jin Woo OhDepartment of Biomedical Engineering and McKusick-Nathans Department of Genetic Medicine, Johns Hopkins University, Baltimore, MD, USA.ORCID http://orcid.org/0000-0002-3545-5481
Wang XiDepartment of Biomedical Engineering and McKusick-Nathans Department of Genetic Medicine, Johns Hopkins University, Baltimore, MD, USA.
Dustin ShigakiDepartment of Biomedical Engineering and McKusick-Nathans Department of Genetic Medicine, Johns Hopkins University, Baltimore, MD, USA.
Wilfred WongComputational & Systems Biology Program, Sloan Kettering Institute, New York City, NY, USA.
Hyein S ChoDevelopmental Biology Program, Sloan Kettering Institute, New York City, NY, USA.
Dylan MurphyWeill Cornell Graduate School of Medical Sciences, Weill Cornell Medicine, New York City, NY, USA.
Ronald CutlerDepartment of Biochemistry, Albert Einstein College of Medicine, Bronx, NY, USA.
Bess P RosenDevelopmental Biology Program, Sloan Kettering Institute, New York City, NY, USA.
Julian PulecioDevelopmental Biology Program, Sloan Kettering Institute, New York City, NY, USA.
Dapeng YangDevelopmental Biology Program, Sloan Kettering Institute, New York City, NY, USA.ORCID http://orcid.org/0000-0001-8687-4486
Rachel A GlennDevelopmental Biology Program, Sloan Kettering Institute, New York City, NY, USA.
Tingxu ChenDevelopmental Biology Program, Sloan Kettering Institute, New York City, NY, USA.
Qing V LiDevelopmental Biology Program, Sloan Kettering Institute, New York City, NY, USA.
Thomas VierbuchenDevelopmental Biology Program, Sloan Kettering Institute, New York City, NY, USA.
Simone SidoliDepartment of Biochemistry, Albert Einstein College of Medicine, Bronx, NY, USA.ORCID http://orcid.org/0000-0001-9073-6641
Effie ApostolouDepartment of Medicine, Weill Cornell Medicine, New York City, NY, USA.ORCID http://orcid.org/0000-0002-8111-0863
Danwei HuangfuDevelopmental Biology Program, Sloan Kettering Institute, New York City, NY, USA. huangfud@mskcc.org.ORCID http://orcid.org/0000-0002-1145-6199
Michael A BeerDepartment of Biomedical Engineering and McKusick-Nathans Department of Genetic Medicine, Johns Hopkins University, Baltimore, MD, USA. mbeer@jhu.edu.ORCID http://orcid.org/0000-0001-9955-3809
Cornell University · USKettering University · USJohns Hopkins University · USMemorial Sloan Kettering Cancer Center · USAlbert Einstein College of Medicine · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
WORD PROCESSORP30CA013330 · NCI · YESHIVA UNIVERSITY · PI STEVEN C. ALMO · 1985 to 2026
$111.2M
Genomic control of gene regulatory networks governing early human lineagedecisionsU01HG012051 · NHGRI · SLOAN-KETTERING INST CAN RESEARCH · PI Michael A Beer, ANNA-KATERINA HADJANTONAKIS · 2021 to 2026
$8.3M
TRAINING PROGRAM IN MOLECULAR AND CELLULAR BIOLOGYT32GM008539 · NIGMS · WEILL MEDICAL COLL OF CORNELL UNIV · PI BROWN, ANTHONY M.C. · 1995 to 2020
$5.0M
Understanding Pancreatic Progenitors for Diabetes Cell-Replacement TherapyR01DK096239 · NIDDK · SLOAN-KETTERING INST CAN RESEARCH · PI HUANGFU, DANWEI · 2012 to 2021
$4.4M
Discovery of diabetes-relevant β cell enhancers through 4D enhancer mapping, integrative analysis, and large-scale CRISPRi perturbation screensU01DK128852 · NIDDK · SLOAN-KETTERING INST CAN RESEARCH · PI APOSTOLOU, EFFIE, HUANGFU, DANWEI · 2020 to 2024
$3.5M
Systematic Identification of Core Regulatory Circuitry from ENCODE DataU01HG009380 · NHGRI · JOHNS HOPKINS UNIVERSITY · PI BEER, MICHAEL A · 2017 to 2021
$2.6M
Sequence-based Machine Learning for Inference of Dynamic Cell State Gene Network ModelsR01HG012367 · NHGRI · JOHNS HOPKINS UNIVERSITY · PI BEER, MICHAEL A · 2022 to 2025
$1.8M
Orbitrap Exploris 480 Basic SystemS10OD030286 · OD · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI SIDOLI, SIMONE · 2021 to 2021
$600k
Using Syntenic Gapped-kmer Composition to Detect Conserved Enhancers where Sequence Alignment FailsR56HG012110 · NHGRI · JOHNS HOPKINS UNIVERSITY · PI BEER, MICHAEL A · 2021 to 2021
$389k
NCI NIH HHS P30 CA008748NCI NIH HHS P30 CA013330NHGRI NIH HHS R01 HG012367NHGRI NIH HHS R56 HG012110NHGRI NIH HHS U01 HG009380NHGRI NIH HHS U01 HG012051NIDDK NIH HHS R01 DK096239NIDDK NIH HHS U01 DK128852NIGMS NIH HHS T32 GM008539NIH HHS S10 OD030286
6 · The paper itself

Abstract

Comprehensive enhancer discovery is challenging because most enhancers, especially those contributing to complex diseases, have weak effects on gene expression. Our gene regulatory network modeling identified that nonlinear enhancer gene regulation during cell state transitions can be leveraged to improve the sensitivity of enhancer discovery. Using human embryonic stem cell definitive endoderm differentiation as a dynamic transition system, we conducted a mid-transition CRISPRi-based enhancer screen. We discovered a comprehensive set of enhancers for each of the core endoderm-specifying transcription factors. Many enhancers had strong effects mid-transition but weak effects post-transition, consistent with the nonlinear temporal responses to enhancer perturbation predicted by the modeling. Integrating three-dimensional genomic information, we were able to develop a CTCF-loop-constrained Interaction Activity model that can better predict functional enhancers compared to models that rely on Hi-C-based enhancer-promoter contact frequency. Our study provides generalizable strategies for sensitive and systematic enhancer discovery in both normal and pathological cell state transitions.

Indexed as

Enhancer Elements, GeneticGene Expression RegulationCell DifferentiationChromatinGene Regulatory NetworksHumansTranscription FactorsChromatinTranscription Factors

Identifiers

PMID37488417
PMCPMC11012226
OpenAlexW4385215761

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.